Literature DB >> 28662459

Agreement between clinical and MINI diagnoses in outpatients with mood and anxiety disorders.

F E A Verhoeven1, L S M A Swaab2, I V E Carlier2, A M van Hemert2, F G Zitman2, H G Ruhé1, R A Schoevers1, E J Giltay3.   

Abstract

BACKGROUND: Standardized Diagnostic Interviews (SDIs) such as the Mini International Neuropsychiatric Interview (MINI) are widely used to systematically screen for psychiatric disorders in research. To support generalizability of results to clinical practice, we assessed agreement between the MINI and clinical diagnoses.
METHODS: Agreement was assessed in a large, real life dataset (n = 7016) using concordance statistics such as sensitivity, specificity, efficiency and area under the curve (AUC).
RESULTS: 41.5% of clinical diagnoses were mood disorders, 26.5% were anxiety disorders. Overall, we found moderate agreement between MINI and clinical diagnoses (median efficiency: 0.92, median AUC: 0.79). For mood disorders, the AUC for all participants showed a range between 0.55 and 0.81 (median: 0.73), and for anxiety disorders the AUC ranged from 0.78 to 0.88 (median: 0.83). The AUC showed better agreement for mood disorders in the single diagnosis group than in the total group (median 0.77 vs. 0.71). For anxiety disorders, the AUC for the single diagnosis group was comparable to the AUC of the total group (median: 0.81 vs. 0.83 respectively). Numbers of false positives were high for both mood and anxiety diagnoses, but less so in the single diagnosis group. LIMITATIONS: Time lag between MINI and clinical diagnosis, the availability of only the primary clinical diagnosis, and relatively high severity of the current sample are limitations of the current study.
CONCLUSIONS: Agreement between MINI and clinical diagnoses was moderate at best, which partly reflects the difference between the different measures used in the current study.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Agreement; Anxiety disorders; Clinical diagnoses; Concordance; MINI; Mood disorders; Routine Outcome Monitoring; Validity

Mesh:

Year:  2017        PMID: 28662459     DOI: 10.1016/j.jad.2017.06.041

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  Inflammatory gene expression in adipose tissue according to diagnosis of anxiety and mood disorders in obese and non-obese subjects.

Authors:  Leticia Coín-Aragüez; Francisco Javier Pavón; Alba Contreras; Adriana-Mariel Gentile; Said Lhamyani; Yolanda De Diego-Otero; Yolanda Casado; Wilfredo Oliva Olivera; Gabriel Olveira; Francisco J Tinahones; Lucía Pérez Costillas; Rajaa El Bekay
Journal:  Sci Rep       Date:  2018-11-30       Impact factor: 4.379

2.  Gender Differences in Developing Biomarker-Based Major Depressive Disorder Diagnostics.

Authors:  Mike C Jentsch; Huibert Burger; Marjolein B M Meddens; Lian Beijers; Edwin R van den Heuvel; Marcus J M Meddens; Robert A Schoevers
Journal:  Int J Mol Sci       Date:  2020-04-25       Impact factor: 5.923

3.  Psychometric Characteristics of the Oxford Grief Memory Characteristics Scale and Its Relationship With Symptoms of ICD-11 and DSM-5-TR Prolonged Grief Disorder.

Authors:  Kirsten V Smith; Jennifer Wild; Anke Ehlers
Journal:  Front Psychiatry       Date:  2022-03-16       Impact factor: 4.157

4.  Identifying the prevalence and predictors of suicidal behaviours for indigenous males in custody.

Authors:  Stephane M Shepherd; Benjamin Spivak; Kerry Arabena; Yin Paradies
Journal:  BMC Public Health       Date:  2018-10-04       Impact factor: 3.295

5.  Recognition of personality disorder and anxiety disorder comorbidity in patients treated for depression in secondary psychiatric care.

Authors:  Marie Asp; Daniel Lindqvist; Johan Fernström; Livia Ambrus; Eva Tuninger; Margareta Reis; Åsa Westrin
Journal:  PLoS One       Date:  2020-01-02       Impact factor: 3.240

6.  Screening for anxiety disorders in third trimester pregnancy: a comparison of four brief measures.

Authors:  Marie-Paule V Austin; Victoria Mule; Dusan Hadzi-Pavlovic; Nicole Reilly
Journal:  Arch Womens Ment Health       Date:  2021-08-05       Impact factor: 3.633

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.